Abstract: The present disclosure provides compositions comprising chemerin and the methods of use thereof. The compositions of the disclosure are useful in the treatment of cancer.

Abstract: The present disclosure provides compositions comprising chemerin and the methods of use thereof. The compositions of the disclosure are useful in the treatment of cancer.

Abstract: The invention provides novel anti-BTLA antibodies, pharmaceutical compositions comprising such antibodies, and therapeutic methods of using such antibodies and pharmaceutical compositions for the treatment of diseases such as cancer or autoimmune disease.

Abstract: ?-NETA analogs are provided for the treatment of inflammatory disease.

Abstract: Embodiments include monoclonal antibodies (mAbs) that recognize SARS-Cov-2 spike protein. The mAbs are capable of distinguishing among variants of the virus. The present disclosure also provides a composition and methods of making and using such a composition for treating, preventing, and/or detecting SARS-CoV-2 infection.

Abstract: The present disclosure provides antibodies that bind to the SARS-CoV-2 spike protein, as well as compositions containing the same, and methods of making and using such a composition for treating, preventing, and/or detecting SARS-CoV-2 infection.

Abstract: A burner control system for improving burner performance and efficiency may determine fuel and air channel or manifold parameters. Determination of parameters may be performed with a sensor connected across the air and fuel channels. A signal from the sensor may control the parameters which in turn affect the amounts of fuel and air to the burner via a controller. Parameter control of the fuel and air in their respective channels may result in more accurate fuel and air ratio control. One or more flow restrictors in fuel and/or air bypass channels may further improve accuracy of the fuel and air ratio. The channels may be interconnected with a pressure or flow divider. Byproducts of combustion in the exhaust, temperatures of gas and air, flame quality and/or other items may be monitored and adjusted with control of the fuel and air ratio for optimum combustion in the burner.

Abstract: The invention provides novel anti-BTLA antibodies, pharmaceutical compositions comprising such antibodies, and therapeutic methods of using such antibodies and pharmaceutical compositions for the treatment of diseases such as cancer or autoimmune disease.

Abstract: ?-NETA analogs are provided for the treatment of inflammatory disease.

Abstract: The invention provides novel anti-BTLA antibodies, pharmaceutical compositions comprising such antibodies, and therapeutic methods of using such antibodies and pharmaceutical compositions for the treatment of diseases such as cancer or autoimmune disease.

Abstract: A controller unit for controlling an ultraviolet (UV) sensor may be excited by an excitation voltage that enables the UV sensor to detect incoming UV light. The UV sensor may provide UV detection events that may be related to the intensity of the incoming UV light. The control unit may include an excitation voltage generator, an event detector, and a controller configured to cause the excitation voltage generator to produce an excitation voltage for a cumulative excitation time that is less than 50% of the time, which may significantly increase the operational lifetime and/or reliability of a UV sensor.

Abstract: A programmable controller for controlling an ultraviolet (UV) sensor may adjust an excitation voltage provided to the UV sensor based at least in part on a programmable sensitivity offset in order to produce an excitation voltage that results in a desired UV sensitivity for the UV sensor. The programmable sensitivity offset may be set for the UV sensor at the factory, set during commissioning of the UV sensor in the field, and/or automatically altered over time to help compensate for a degradation in sensitivity of the UV sensor.

Abstract: A burner control system for improving burner performance and efficiency. The system may determine fuel and air channel or manifold parameters. Determination of parameters may be performed with a sensor connected across the air and fuel channels. A signal from the sensor may control the parameters which in turn affect the amounts of fuel and air to the burner via a controller. Parameter control of the fuel and air in their respective channels may result in more accurate fuel and air ratio control. One or more flow restrictors in fuel and/or air bypass channels may further improve accuracy of the fuel and air ratio. The channels may be interconnected with a pressure or flow divider. Byproducts of combustion in the exhaust, temperatures of gas and air, flame quality and/or other items may be monitored and adjusted with control of the fuel and air ratio for optimum combustion in the burner.

Abstract: A programmable controller for controlling an ultraviolet (UV) sensor may adjust an excitation voltage provided to the UV sensor based at least in part on a programmable sensitivity offset in order to produce an excitation voltage that results in a desired UV sensitivity for the UV sensor. The programmable sensitivity offset may be set for the UV sensor at the factory, set during commissioning of the UV sensor in the field, and/or automatically altered over time to help compensate for a degradation in sensitivity of the UV sensor.

Abstract: The present disclosure provides compositions comprising chemerin and the methods of use thereof. The compositions of the disclosure are useful in the treatment of cancer.

Abstract: Utilizing a quench time to deionize an ultraviolet (UV) sensor tube are described herein. One method includes monitoring firing events within a UV sensor tube, where a particular firing event initiates arming the UV sensor tube, initiating a quench time to deionize the UV sensor tube, where the quench time includes, disarming the UV sensor tube to prevent a firing event.

Abstract: Chemerin is a chemoattractant that selectively directs intra-tumor recruitment of CMKLR1+ cells. Blockade of CCRL2 from binding to chemerin in non-neoplastic tumor cells, e.g. peri-tumor stromal and/or hematopoietic cells allows for redistribution of chemerin into the tumor and enhanced responsiveness against a tumor.

Abstract: Methods, devices, and systems for determining failure of an ultraviolet (UV) sensor are described herein. One device includes a memory, and a processor configured to execute executable instructions stored in the memory to reduce an excitation voltage of a UV sensor until no conduction occurs in the UV sensor, increase, upon no conduction occurring in the UV sensor, the excitation voltage of the UV sensor until a conduction event occurs, compare the excitation voltage at which the conduction event occurs to a reference voltage, and determine whether the UV sensor has failed based on the comparison.

Abstract: A burner control system for improving burner performance and efficiency. The system may determine fuel and air channel or manifold parameters. Determination of parameters may be performed with a sensor connected across the air and fuel channels. A signal from the sensor may control the parameters which in turn affect the amounts of fuel and air to the burner via a controller. Parameter control of the fuel and air in their respective channels may result in more accurate fuel and air ratio control. One or more flow restrictors in fuel and/or air bypass channels may further improve accuracy of the fuel and air ratio. The channels may be interconnected with a pressure or flow divider. Byproducts of combustion in the exhaust, temperatures of gas and air, flame quality and/or other items may be monitored and adjusted with control of the fuel and air ratio for optimum combustion in the burner.

Abstract: Chemerin is a chemoattractant that selectively directs intra-tumor recruitment of CMKLR1+ cells. Blockade of CCRL2 from binding to chemerin in non-neoplastic tumor cells, e.g. peri-tumor stromal and/or hematopoietic cells allows for redistribution of chemerin into the tumor and enhanced responsiveness against a tumor.